EMEIS SA, a prominent entity within the Health Care sector, operates under the broader industry classification of Health Care Providers & Services. The company is publicly traded on the NYSE Euronext Paris, with its financial activities denominated in Euros (EUR). As of October 8, 2026, EMEIS SA’s close price was recorded at 10.05 EUR. Over the past year, the company’s stock has experienced significant fluctuations, reaching a 52-week high of 16.01 EUR on October 28, 2025, and a 52-week low of 9.535 EUR on October 7, 2026.
The market capitalization of EMEIS SA stands at approximately 1,618,088,320 EUR, reflecting its substantial presence in the health care market. However, the company’s financial performance, as indicated by its Price Earnings (P/E) ratio, presents a challenging picture. With a P/E ratio of -8.21, EMEIS SA is currently experiencing negative earnings, which may raise concerns among investors regarding its profitability and financial health.
EMEIS SA is part of the Orpea SA group, a well-known health care provider specializing in nursing homes for older clients across various stages of dependency. This affiliation underscores EMEIS SA’s commitment to delivering comprehensive care services tailored to the needs of the elderly population in France. The company’s strategic focus on this demographic aligns with broader trends in the health care industry, where the demand for specialized elderly care services continues to grow.
In summary, while EMEIS SA maintains a significant market presence and is strategically positioned within the health care sector, its current financial metrics, particularly the negative P/E ratio, highlight areas that may require attention and strategic adjustments. Investors and stakeholders will likely monitor the company’s efforts to improve its financial performance and capitalize on its core competencies in elderly care services.
